![](/img/cover-not-exists.png)
Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro
Binder, Christian, Sellberg, Felix, Cvetkovski, Filip, Berglund, Erik, Berglund, DavidVolume:
11
Journal:
Frontiers in Immunology
DOI:
10.3389/fimmu.2020.592553
Date:
November, 2020
File:
PDF, 4.15 MB
2020